Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations from the last five years
Projects
- 1 Active
-
Role of microRNA-22 in Duchenne Muscular Dystrophy
Tomasini, S. (PI), Panella, R. (Supervisor) & Kauppinen, S. (Supervisor)
01/02/2024 → 31/12/2025
Project: PhD Project
-
The Role of microRNA-22 in Metabolism
Tomasini, S., Vigo, P., Margiotta, F., Scheele, U. S., Panella, R. & Kauppinen, S., 17 Jan 2025, In: International Journal of Molecular Sciences . 26, 2, 21 p., 782.Research output: Contribution to journal › Review article › peer-review
Open AccessFile24 Downloads (Pure) -
Inhibitory nucleic acids and methods of use thereof
Naar, A. M. (Inventor), Gilroy, C. (Inventor), Xu, L. (Inventor), Kauppinen, S. (Inventor), Løvendorf, M. B. (Inventor) & Petri, A. (Inventor), 30 May 2024, Patent No. WO/2024/112653, 20 Nov 2023, Priority date 22 Nov 2022, Priority No. 63/427,254Research output: Patent
-
Targeting the NRF2 pathway for disease modification in neurodegenerative diseases: mechanisms and therapeutic implications
Mayer, C., Riera-Ponsati, L., Kauppinen, S., Klitgaard, H., Erler, J. T. & Hansen, S. N., 2024, In: Frontiers in Pharmacology. 15, 1437939.Research output: Contribution to journal › Review article › peer-review
Open AccessFile13 Citations (Scopus)7 Downloads (Pure) -
Assessment of immunostimulatory responses to the antimiR-22 oligonucleotide compound RES-010 in human peripheral blood mononuclear cells
Panella, R., Zanderigo, F., Morandini, F., Federico, D., Vicentini, E., Andreetta, F., Toniolo, A. & Kauppinen, S., 23 Mar 2023, In: Frontiers in Pharmacology. 14, 1125654.Research output: Contribution to journal › Journal article › Research › peer-review
Open AccessFile2 Citations (Scopus)75 Downloads (Pure) -
In vivo effects of a novel series of antisense oligonucleotide targeting microRNA-134 in experimental temporal lobe epilepsy
Mamad, O., Langa, E., Hansen, S. N., Erler, J., Kauppinen, S., Klitgaard, H. & Henshall, D. C., Nov 2023, In: Epilepsia. 64, S2, p. 309 1 p., 897 .Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Datasets
-
Inhibition of miR-9 regulates HuR and DICER1 and blocks Hodgkin Lymphoma tumor outgrowth
Leucci, E. (Contributor), Zriwil, A. (Contributor), Gregersen, L. H. (Contributor), Jensen, K. T. (Contributor), Obad, S. (Contributor), Bellan, C. (Contributor), Leoncini, L. (Contributor), Kauppinen, S. (Contributor) & Lund, A. H. (Contributor), Gene Expression Omnibus, 2012
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE27529
Dataset
-
Gene expression profile of L428 cell line with inhibited expression of miR-9
Leucci, E. (Contributor), Zriwil, A. (Contributor), Obad, S. (Contributor), Bellan, C. (Contributor), Leoncini, L. (Contributor) & Kauppinen, S. (Contributor), ArrayExpress, 2012
https://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27529
Dataset
-
Transcription profiling by array of mouse heart with microRNA knock down of mmu-miR-155 in mice with actual viral myocarditis
Papageorgiou, A. (Contributor), Verhesen, W. (Contributor), Carai, P. (Contributor), Lindow, M. (Contributor), Obad, S. (Contributor), Summer, G. (Contributor), Hazebroek, M. (Contributor), Van Leeuwen, R. (Contributor), Wijnands, E. (Contributor), Carmeliet, P. (Contributor), Kauppinen, S. (Contributor), Schroen, B. (Contributor) & Heymans, S. (Contributor), ArrayExpress, 2012
https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-3395
Dataset
-
Transcription profiling of mouse liver after silencing of microRNAs by seed-targeting tiny LNAs - in vivo antimiR-122
Obad, S. (Contributor), Petri, A. (Contributor), Heidenblad, M. (Contributor), Broom, O. (Contributor), Ruse, C. (Contributor), Fu, C. (Contributor), Lindow, M. (Contributor), Stenvang, J. (Contributor), Koch, T. (Contributor), Pappin, D. (Contributor) & Kauppinen, S. (Contributor), ArrayExpress, 2011
https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2802
Dataset
-
Transcription profiling of human HeLa cells after silencing of microRNAs by seed-targeting tiny LNAs - in vitro antimiR-21
Obad, S. (Contributor), Petri, A. (Contributor), Heidenblad, M. (Contributor), Broom, O. (Contributor), Ruse, C. (Contributor), Fu, C. (Contributor), Lindow, M. (Contributor), Stenvang, J. (Contributor), Koch, T. (Contributor), Pappin, D. (Contributor) & Kauppinen, S. (Contributor), ArrayExpress, 2011
https://www.ebi.ac.uk/arrayexpress/experiments/E-MEXP-2803
Dataset
Press/Media
-
MicroRNAs won the Nobel — will they ever be useful as medicines? On Oct 12, 2024
12/10/2024
1 item of Media coverage
Press/Media: Press / Media
-
MicroRNAs won the Nobel — will they ever be useful as medicines?
09/10/2024
1 item of Media coverage
Press/Media: Press / Media
-
Näär receives USD 9.2 million Novo Nordisk Foundation grant
26/07/2024
1 item of Media coverage
Press/Media: Press / Media
-
Resalis Therapeutics Announces Seed Financing of €10 Million to Fund Non-coding RNA-based Therapeutics for Metabolic Diseases
22/02/2023
40 items of Media coverage
Press/Media: Press / Media
-
Coronavacciner har vist at RNA-medicin virker: ”Det vil forandre alting”
19/07/2021 → 20/07/2021
3 items of Media coverage
Press/Media: Press / Media
Impacts
-
Antisense Oligonucleotides Targeting SARS-CoV-2
Naar, A. M. (Participant), Kauppinen, S. (Participant) & Zhu, C. (Participant)
Impact: Quality of life impact